Repeated treatment with low dose of [131I]MIBG with good response and without toxicity

被引：0
|
作者：
Rossetti, Lisa-Maria [1 ]
Kroiss, Alexander Stephan [1 ]
Uprimny, Christian [1 ]
Buxbaum, Sabine [1 ]
Virgolini, Irene Johanna [1 ]
机构：
[1] Univ Med Innsbruck, Dept Med Nucl, Innsbruck, Austria
来源：
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 2022年 / 41卷
关键词：
D O I：
10.1016/j.remn.2020.08.003
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 50 条
  • [21] Repeated treatment with I-131-MIBG in patients with metastatic neural trest tumors
    Balink, H.
    Lam, M. G. E. H.
    de Klerk, J. M. H.
    van Rijk, P. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S326 - S326
  • [22] Assessment of surface contamination of low-dose radioactive iodine (131I) treatment container
    Ryu, Chan-Ju
    NUCLEAR MEDICINE COMMUNICATIONS, 2025, 46 (03) : 187 - 192
  • [23] EXCRETION OF VOLATILE 131I FROM RATS FOLLOWING ADMINISTRATION OF NA131I OR MIBG-131I
    Li, Chunsheng
    Sadi, Baki
    Wyatt, Heather
    Bugden, Michelle
    Wilkinson, Diana
    Cornett, Jack
    Kramer, Gary H.
    RADIATION PROTECTION DOSIMETRY, 2012, 148 (02) : 143 - 148
  • [24] Dosimetry for Repeated 131I-mIBG Therapy of Phaeochromoblastoma
    Happel, C.
    Selkinski, I.
    Middendorp, M.
    Sauter, B.
    Plastowez, W.
    Diener, J.
    Kranert, W. T.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [25] 131I MIBG therapy in neuroblastoma:: Mechanisms, rationale, and current status
    Tepmongkol, S
    Heyman, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (06): : 427 - 431
  • [26] Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors
    Liu, B.
    Zhuang, H.
    Servaes, S.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (01): : 21 - 28
  • [27] Diagnostic scan with low dose I-123 MIBG is inferior to I-131 MIBG post-treatment scan in malignant pheochromocytoma and paraganglioma
    Kayano, D.
    Inaki, A.
    Nakamura, A.
    Wakabayashi, H.
    Fukuoka, M.
    Mochizuki, T.
    Taki, J.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S303 - S303
  • [28] Low activity treatment with 131I in differentiated thyroid cancer
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Agudelo-Cifuentes, M.
    Bernal-Vergara, J.
    Bello-Arques, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S608 - S609
  • [29] Predictive factors of early FDG-PET response to [131I] MIBG treatment for unresectable or metastatic pheochromocytomas and paragangliomas (PPGLs)
    Takenaka, Junki
    Watanabe, Shiro
    Abe, Takashige
    Tsuchikawa, Takahiro
    Takeuchi, Satoshi
    Hirata, Kenji
    Kimura, Rina
    Wakabayashi, Naoto
    Shinohara, Nobuo
    Kudo, Kohsuke
    NEUROENDOCRINOLOGY, 2024, 114 (09) : 816 - 826
  • [30] Ablative treatment with 131I in low-risk papillary thyroid cancer: is low-dose as effective as high-dose?
    Unceta Barrenechea, A. Roteta
    Andres Gracia, A.
    Tardin Cardoso, L.
    Saker Diffalah, Y.
    Razola Alba, P.
    Escalera Temprado, T.
    Delgado Castro, M.
    Prats Rivera, E.
    Abos Olivares, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S362 - S363
12345